Download Free The Anthrax Immunization Program Book in PDF and EPUB Free Download. You can read online The Anthrax Immunization Program and write the review.

The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA. The Anthrax Vaccine: Is It Safe? Does It Work? reports the study's conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine.
In this provocative look at the US military from the Persian Gulf War through the 2003 invasion of Iraq, investigative journalist Gary Matsumoto contends that an anthrax vaccine dispensed by the Department of Defense was the cause of Gulf War Syndrome and the origins of a massive cover-up. Matsumoto calls it the worst friendly-fire incident in military history. A skillfully-woven narrative that serves as a warning about this man-made epidemic, Vaccine A is a much needed account of just what went wrong, and why.
The Vaccine Safety Datalink (VSD) is a large, linked database of patient information that was developed jointly by CDC and several private managed care organizations in 1991. It includes data on vaccination histories, health outcomes, and characteristics of more than 7 million patients of eight participating health organizations. Researchers from CDC and the managed care groups have used VSD information to study whether health problems are associated with vaccinations. The subsequent VSD data sharing program was launched in 2002 to allow independent, external researchers access to information in the database. In this report, the committee that was asked to review aspects of this program recommends that two new oversight groups are needed to ensure that the policies and procedures of the VSD and its data sharing program are implemented as fairly and openly as possible.
In this “engrossing, well-documented, and highly readable” (San Francisco Chronicle) New York Times bestseller, three veteran reporters draw on top sources inside and outside the U.S. government to reveal Washington's secret strategies for combating germ warfare and the deadly threat of biological and chemical weapons. Today Americans have begun to grapple with two difficult truths: that there is no terrorist threat more horrifying—and less understood—than germ warfare, and that it would take very little to mount a devastating attack on American soil. Featuring an inside look at how germ warfare has been waged throughout history and what form its future might take (and in whose hands), Germs reads like a gripping detective story told by fascinating key figures: American and Soviet medical specialists who once made germ weapons but now fight their spread, FBI agents who track Islamic radicals, the Iraqis who built Saddam Hussein's secret arsenal, spies who travel the world collecting lethal microbes, and scientists who see ominous developments on the horizon. With clear scientific explanations and harrowing insights, Germs is a vivid, masterfully written—and timely—work of investigative journalism.
Introduction : our immunization social order -- How are vaccines political? -- The solution of the vaccine court -- Health and rights in the vaccine-critical movement -- Knowing vaccine injury through law -- What counts as evidence? -- The autism showdown -- Conclusion : the epistemic politics of the vaccine court.
This fourth edition of the anthrax guidelines encompasses a systematic review of the extensive new scientific literature and relevant publications up to end 2007 including all the new information that emerged in the 3-4 years after the anthrax letter events. This updated edition provides information on the disease and its importance, its etiology and ecology, and offers guidance on the detection, diagnostic, epidemiology, disinfection and decontamination, treatment and prophylaxis procedures, as well as control and surveillance processes for anthrax in humans and animals. With two rounds of a rigorous peer-review process, it is a relevant source of information for the management of anthrax in humans and animals.
At the turn of the twenty-first century, the United States contended with a state-run biological warfare program, bioterrorism, and a pandemic. Together, these threats spurred large-scale government demand for new vaccines, but few have materialized. A new anthrax vaccine has been a priority since the first Gulf War, but twenty years and a billion dollars later, the United States still does not have one. This failure is startling. Historically, the United States has excelled at responding to national health emergencies. World War II era programs developed ten new or improved vaccines, often in time to meet the objectives of particular military missions. Probing the history of vaccine development for factors that foster timely innovation, Kendall Hoyt discovered that vaccine innovation has been falling, not rising, since World War II. This finding is at odds with prevailing theories of market-based innovation and suggests that a collection of nonmarket factors drove mid-century innovation. Ironically, many late-twentieth-century developments that have been celebrated as a boon for innovation—the birth of a biotechnology industry and the rise of specialization and outsourcing—undercut the collaborative networks and research practices that drove successful vaccine projects in the past. Hoyt’s timely investigation teaches important lessons for our efforts to rebuild twenty-first-century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.
As the world pins its hope for the end of the coronavirus pandemic to the successful rollout of vaccines, this book offers a vital long view of such efforts—and our resistance to them. At a time when vaccines are a vital tool in the fight against COVID-19 in all its various mutations, this hard-hitting book takes a longer historical perspective. It argues that globalization and cuts to healthcare have been eroding faith in the institutions producing and providing vaccines for more than thirty years. It tells the history of immunization from the work of early pioneers such as Louis Pasteur and Robert Koch through the eradication of smallpox in 1980, to the recent introduction of new kinds of genetically engineered vaccines. Immunization exposes the limits of public health authorities while suggesting how they can restore our confidence. Public health experts and all those considering vaccinations should read this timely history.
For the first time, Pulitzer Prize–winning journalist David Willman tells the whole gripping story of the hunt for the anthrax killer who terrorized the country in the dark days that followed the September 11th attacks. Letters sent surreptitiously from a mailbox in New Jersey to media and political figures in New York, Florida, and Washington D.C. killed five people and infected seventeen others. For years, the case remained officially unsolved—and it consumed the FBI and became a rallying point for launching the Iraq War. Far from Baghdad, at Fort Detrick, Maryland, stood Bruce Ivins: an accomplished microbiologist at work on patenting a next-generation anthrax vaccine. Ivins, it turned out, also was a man the FBI consulted frequently to learn the science behind the attacks. The Mirage Man reveals how this seemingly harmless if eccentric scientist hid a sinister secret life from his closest associates and family, and how the trail of genetic and circumstantial evidence led inexorably to him. Along the way, Willman exposes the faulty investigative work that led to the public smearing of the wrong man, Steven Hatfill, a scientist specializing in biowarfare preparedness whose life was upended by media stakeouts and op-ed-page witch hunts. Engrossing and unsparing, The Mirage Man is a portrait of a deeply troubled scientist who for more than twenty years had unlimited access to the U.S. Army’s stocks of deadly anthrax. It is also the story of a struggle for control within the FBI investigation, the missteps of an overzealous press, and how a cadre of government officials disregarded scientific data while spinning the letter attacks into a basis for war. As The Mirage Man makes clear, America must, at last, come to terms with the lessons to be learned from what Bruce Ivins wrought. The nation’s security depends on it. From the Hardcover edition.